MedTrace Logo

Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease

NCT04943081 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-06-29

No results posted yet for this study

Summary

The study aims to evaluate the effect of percutaneous nephrolithotomy (PCNL) on estimated glomerular filtration rate (eGFR) in patients with stage 2-4 chronic kidney disease

Conditions

  • Percutaneous Nephrolithotomy

Interventions

PROCEDURE

Percutaneous nephrolithotomy

Percutaneous nephrolithotomy (PCNL) is a technique used to remove complex renal stones, or stones resistant to shockwave lithotripsy. A tube is placed through the incision in the kidney, under X-ray guidance, and renal stones are extracted by using nephroscope

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Adel Kurkar · Assiut University

  • Ahmed Moeen · Assiut University

  • Amr Abo-Faddan · Assiut University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-07-01
Completion
2022-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943081 on ClinicalTrials.gov